Naixia Zhang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Topics

Cell Proliferation

Cognitive Decline

Binding Protein

Top Venues

The journal of physical chemistry. B

Journal of medicinal chemistry

Molecules (Basel, Switzerland)

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Chen Zhou, Jingjing Zhang, Xinwen Luo, Fulin Lian, Yangyang Zeng, Zhenqing Zhang, Hai Yan Zhang, Naixia Zhang
Sodium Oligomannate Electrostatically Binds to Aβ and Blocks Its Aggregation. The journal of physical chemistry. B (2023)
Chen Zhou, Jingjing Zhang, Xinwen Luo, Fulin Lian, Yangyang Zeng, Zhenqing Zhang, Hai Yan Zhang, Naixia Zhang
Sodium Oligomannate Electrostatically Binds to Aβ and Blocks Its Aggregation. The journal of physical chemistry. B 127 (9) (2023)
Chen Zhou, Jingjing Zhang, Xinwen Luo, Fulin Lian, Yangyang Zeng, Zhenqing Zhang, Hai Yan Zhang, Naixia Zhang
Sodium Oligomannate Electrostatically Binds to Aβ and Blocks Its Aggregation. The journal of physical chemistry. B 127 (9) (2023)
Chen Zhou, Jingjing Zhang, Xinwen Luo, Fulin Lian, Yangyang Zeng, Zhenqing Zhang, Hai Yan Zhang, Naixia Zhang
Sodium Oligomannate Electrostatically Binds to Aβ and Blocks Its Aggregation. The journal of physical chemistry. B 127 (9) (2023)
Mengying Zhu, Hui Wang, Yiluan Ding, Yuanyuan Yang, Zhuo Xu, Li Shi, Naixia Zhang
Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin-specific protease 2 and downregulates its substrate protein cyclin D1. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 (5) (2022)
Tonghai Liu, Wenjia Shi, Yiluan Ding, Qiqi Wu, Bei Zhang, Naixia Zhang, Mingliang Wang, Daohai Du, Hao Zhang, Bo Han, De-An Guo, Jie Zheng, Qi Li, Cheng Luo
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase. ACS medicinal chemistry letters 13 (11) (2022)
Daohai Du, Dandan Xu, Licheng Zhu, Giulia Stazi, Clemens Zwergel, Yanli Liu, Zhongyuan Luo, Yuanqing Li, Yuanyuan Zhang, Kongkai Zhu, Yiluan Ding, Jingqiu Liu, Shijie Fan, Kaiyan Zhao, Naixia Zhang, Xiangqian Kong, Hualiang Jiang, Kaixian Chen, Kehao Zhao, Sergio Valente, Jinrong Min, Wenhu Duan, Cheng Luo
Structure-Guided Development of Small-Molecule PRC2 Inhibitors Targeting EZH2-EED Interaction. Journal of medicinal chemistry 64 (12) (2021)
Li Shi, Naixia Zhang
Applications of Solution NMR in Drug Discovery. Molecules (Basel, Switzerland) 26 (3) (2021)
Huifang Hu, Qing Wang, Jingwen Du, Zhijun Liu, Yiluan Ding, Hongjuan Xue, Chen Zhou, Linyin Feng, Naixia Zhang
Aha1 Exhibits Distinctive Dynamics Behavior and Chaperone-Like Activity. Molecules (Basel, Switzerland) 26 (7) (2021)
Hui Wang, Qian Meng, Yiluan Ding, Muya Xiong, Mengying Zhu, Yuanyuan Yang, Haixia Su, Lei Gu, Yechun Xu, Li Shi, Hu Zhou, Naixia Zhang
USP28 and USP25 are downregulated by Vismodegib in vitro and in colorectal cancer cell lines. The FEBS journal 288 (4) (2020)
Haixia Su, Yi Zou, Guofeng Chen, Huixia Dou, Hang Xie, Xiaojing Yuan, Xianglei Zhang, Naixia Zhang, Minjun Li, Yechun Xu
Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation. Journal of medicinal chemistry 63 (8) (2020)